Search results
Jump to navigation
Jump to search
- ...e with MBL can develop other B-cell disorders, such as chronic lymphocytic leukemia (CLL). ...orders, such as chronic lymphocytic leukemia (CLL). Also called monoclonal B-cell lymphocytosis {{dictionary-stub}} [[Category:Dictionary of medicine]]607 bytes (92 words) - 07:41, 12 January 2023
- '''B-cell prolymphocytic leukemia''' ('''B-PLL''') is a rare type of [[leukemia]] characterized by the overproduction of [[B cell|B cells]], a type of [[wh The term "B-cell prolymphocytic leukemia" is pronounced as "bee-sell pro-lim-fo-si-tik loo-kee-mee-uh".2 KB (293 words) - 19:43, 7 February 2024
- == B-cell Leukemia == ...r]] that originates in the [[B cells]] of the [[immune system]]. The term "leukemia" is derived from the Greek words "leukos" (λευκός), meaning "white",2 KB (304 words) - 04:21, 9 February 2024
- ...ell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and acute B-cell leukemia who are CD20 positive. Rituximab is also being studied to treat other disea ...ell non-Hodgkin's lymphoma, chronic lymphocytic leukemia, and acute B-cell leukemia who are CD20 positive. Rituximab is also being studied to treat other disea1 KB (160 words) - 19:22, 12 January 2023
- ...arge B-cell lymphoma]], [[follicular lymphoma]], and [[chronic lymphocytic leukemia]]. B-cell lymphomas: /biː sɛl lɪmˈfoʊməz/2 KB (261 words) - 22:10, 14 February 2024
- ...hocytic leukemia and children 6 months and older elderly with acute B-cell leukemia. It is used in patients whose cancer is CD20 positive. ...hocytic leukemia and children 6 months and older elderly with acute B-cell leukemia. It is used in patients whose cancer is CD20 positive. It is also being stu1 KB (189 words) - 11:13, 10 January 2023
- ...n B cells from earliest recognizable B-lineage cells during development to B-cell blasts but is lost on maturation to plasma cells. Its expression on B cells ...ia]], including acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL). CD19-targeted therapies, such as [[CAR T-cell therapy]], have shown2 KB (218 words) - 20:41, 12 February 2024
- ...{{Pronunciation}} (KAM path) drug used to treat B-cell chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. ...{{Pronunciation}} (KAM path) drug used to treat B-cell chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. Campat724 bytes (109 words) - 23:51, 10 January 2023
- ...co-ri-ta-mab) is a [[bispecific antibody]] designed for the treatment of [[B-cell]] malignancies. It is currently under investigation in clinical trials. ...allows T-cells to directly kill the B-cells, which are often cancerous in B-cell malignancies.1 KB (146 words) - 14:37, 6 February 2024
- ...uzumab (A-lem-TOO-zoo-mab) A drug used to treat B-cell chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. ...tion}} (A-lem-TOO-zoo-mab) A drug used to treat B-cell chronic lymphocytic leukemia. It is also being studied in the treatment of other types of cancer. Alemtu742 bytes (107 words) - 04:08, 8 January 2023
- ...including [[Chronic myelogenous leukemia]] (CML) and [[Acute lymphoblastic leukemia]] (ALL). ...Region) gene, located on chromosome 22, and the '''ABL''' (Abelson murine leukemia viral oncogene homolog 1) gene, located on chromosome 9. When these two chr1 KB (192 words) - 22:44, 14 February 2024
- ...follicular lymphoma, diffuse large B-cell lymphoma, or chronic lymphocytic leukemia. Rituximab attaches to a protein called CD20, which is found on B cells (a ...follicular lymphoma, diffuse large B-cell lymphoma, or chronic lymphocytic leukemia. Rituximab attaches to a protein called CD20, which is found on B cells (a1 KB (168 words) - 12:37, 12 January 2023
- ...with certain types of B-cell non-Hodgkin's lymphoma or chronic lymphocytic leukemia that are CD20 positive. It is also being studied in the treatment of other ...with certain types of B-cell non-Hodgkin's lymphoma or chronic lymphocytic leukemia that are CD20 positive. It is also being studied in the treatment of other1 KB (156 words) - 08:42, 14 January 2023
- ...with certain types of B-cell non-Hodgkin's lymphoma or chronic lymphocytic leukemia that are CD20 positive. It is also being studied in the treatment of other ...with certain types of B-cell non-Hodgkin's lymphoma or chronic lymphocytic leukemia that are CD20 positive. It is also being studied in the treatment of other1 KB (156 words) - 15:33, 12 January 2023
- ...with certain types of B-cell non-Hodgkin's lymphoma or chronic lymphocytic leukemia that are CD20 positive. It is also being studied in the treatment of other ...with certain types of B-cell non-Hodgkin's lymphoma or chronic lymphocytic leukemia that are CD20 positive. It is also being studied in the treatment of other1 KB (158 words) - 23:07, 13 January 2023
- ..., which is found on B cells (a type of white blood cell) and some types of leukemia and lymphoma cells. HuMax-CD20 can block CD20 and help the immune system ki ..., which is found on B cells (a type of white blood cell) and some types of leukemia and lymphoma cells. HuMax-CD20 can block CD20 and help the immune system ki1 KB (181 words) - 19:39, 11 January 2023
- ...al antibody]] designed for the treatment of [[B-cell]] chronic lymphocytic leukemia (B-CLL). It is a [[biopharmaceutical]] product that was developed by Biogen * [[B-cell Chronic Lymphocytic Leukemia]]1 KB (157 words) - 17:36, 6 February 2024
- The ABL gene is named after the Abelson murine leukemia virus, which was discovered to carry a version of this gene. The term "ABL" ...been associated with certain types of cancer, most notably chronic myeloid leukemia (CML). In CML, a genetic rearrangement occurs between chromosomes 9 and 22,2 KB (275 words) - 23:19, 3 February 2024
- ...rug]] used in the treatment of certain types of [[cancer]], specifically [[B-cell]] malignancies. Tirabrutinib is used in the treatment of [[chronic lymphocytic leukemia]] (CLL) and [[mantle cell lymphoma]] (MCL), two types of cancer that affect2 KB (228 words) - 02:57, 7 February 2024
- ...id leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). ...oid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who are resistant to or cannot tolerate other treatments. It work2 KB (251 words) - 20:04, 5 February 2024